Stay updated on VELIA Clinical Trial: Veliparib in Ovarian Cancer
Sign up to get notified when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.

Latest updates to the VELIA Clinical Trial: Veliparib in Ovarian Cancer page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications section text updated: it now states that publications are automatically filled from PubMed and includes Revision: v3.3.2, while the previous PubMed description and Revision: v3.2.0 are removed.SummaryDifference0.0%

- Check28 days agoChange DetectedThe government funding status banner at the top of the page is removed. Standard study details remain unchanged.SummaryDifference0.1%

- Check42 days agoChange DetectedThe two screenshots show the same ClinicalTrials.gov page with no changes to the title, sections, or data. The content and layout appear identical.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference1%

- Check78 days agoChange DetectedAdded version label v3.1.0 and removed a specific resource reference (Ovarian cancer) and the older version tag v3.0.2. Overall, the changes are administrative with minimal impact on core content or user-facing information.SummaryDifference0.2%

- Check93 days agoChange DetectedPrimarily a minor version bump from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, with no changes to core content, pricing, or availability.SummaryDifference0.1%

Stay in the know with updates to VELIA Clinical Trial: Veliparib in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.